4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Werewolf Therapeutics, Inc. (HOWL) operates in the Biotechnology industry and is headquartered in Watertown, United States with about 14 employees. Its market capitalization is roughly $18 million. In the fiscal year ended 2025-12-31, HOWL reported $0M in revenue and ($61M) in net income.
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $2M | $20M | $16M | — |
| Operating Income (EBIT) | ($61M) | ($74M) | ($40M) | ($56M) | — |
| Net Income | ($61M) | ($70M) | ($37M) | ($54M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($13M) | ($9M) | ($16M) | ($18M) | ($18M) | — |
| Net Income | ($14M) | ($8M) | ($16M) | ($18M) | ($18M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $69M | $127M | $175M | $160M | — |
| Total Liabilities | $45M | $54M | $64M | $38M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HOWL viewer.
About TickerBase · Data methodology & sources